Aligos Therapeutics Inc
NASDAQ:ALGS
Aligos Therapeutics Inc
NASDAQ:ALGS
Price:
6.35
USD
-1.4%
Market Closed
Market Cap:
$39.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
A
|
argenx SE
F:1AE
|
NL |
|
Inventiva SA
PAR:IVA
|
FR |
|
Vidrala SA
F:VIR
|
ES |
|
Tyson Foods Inc
NYSE:TSN
|
US |
|
A
|
Aluminum Corp of China Ltd
XBER:AOC
|
CN |
|
Dentsu Group Inc
F:DEN
|
JP |
|
R
|
Rockwell Automation Inc
XHAM:RWL
|
US |
|
W
|
Wells Fargo & Co
SGO:WFC
|
US |
|
S
|
Sanofi SA
BMV:SNYN
|
FR |
|
Kimberly-Clark Corp
NASDAQ:KMB
|
US |
|
C
|
Compagnie Generale des Etablissements Michelin SCA
XBER:MCH
|
FR |
|
C
|
Cencora Inc
XBER:ABG
|
US |
|
M
|
Mondelez International Inc
BMV:MDLZ
|
US |
Multiples-Based Value
The Multiples-Based Value for Aligos Therapeutics Inc (ALGS) under the Base Case is hidden
USD.
Compared with the current market price of 6.35 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALGS Multiples-Based Value
LOCKED
